Mallolas
Hospital Clínic · Hospital Clínic i Provincial de Barcelona · Hospital Clinic of Barcelona
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Mallolas as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 02:33 UTC. Open this list on ClinicalTrials.gov
- Ph4NCT02470650 · Cost-effectiveness of Different Antiretroviral Treatment in Patients HIV NaiveJuan A. Arnaiz · withdrawn · Patient Compliance, Antiretroviral Therapy Intolerance · principal investigator
- Ph3NCT01718301 · HIV Patients With Chronic Hepatitis C Genotype 1 Infection Who Failed Previously to Peginterferon /RibavirinAnna Cruceta · terminated · Hepatitis C, HIV Infections, COINFECTION · principal investigator
- N/ANCT01258374 · Dual Therapy With Raltegravir and Darunavir/Ritonavir in HIV Infected Patients.Hospital Clinic of Barcelona · completed · Integrase Inhibitors, HIV; HIV PROTEASE INHIB · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 02:33 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 02:33 UTC. The ranking covers the 200 most relevant of 52 PubMed records, and a shared surname and initials can bring in a namesake. All 52 on PubMed
- 300 citationsRCR 7.7
- 251 citationsRCR 8.9
- 229 citationsRCR 8.6
- Boceprevir versus placebo with pegylated interferon alfa-2b and ribavirin for treatment of hepatitis C virus genotype 1 in patients with HIV: a randomised, double-blind, controlled phase 2 trial.Lancet Infect Dis · 2013159 citationsRCR 5.4
- 154 citationsRCR 4.4
- 130 citationsRCR 5.1
- High incidence of herpes zoster in patients with AIDS soon after therapy with protease inhibitors.Clin Infect Dis · 1998111 citationsRCR 3.5
- Impact of switching from human immunodeficiency virus type 1 protease inhibitors to efavirenz in successfully treated adults with lipodystrophy.Clin Infect Dis · 2000109 citationsRCR 2.9
- Switching to Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate (DOR/3TC/TDF) Maintains HIV-1 Virologic Suppression Through 48 Weeks: Results of the DRIVE-SHIFT Trial.J Acquir Immune Defic Syndr · 201986 citationsRCR 4.5
- 84 citationsRCR 2.3